ATE474596T1 - Impfstoff gegen humanes papillomavirus zur oralen verabreichung - Google Patents
Impfstoff gegen humanes papillomavirus zur oralen verabreichungInfo
- Publication number
- ATE474596T1 ATE474596T1 AT05782348T AT05782348T ATE474596T1 AT E474596 T1 ATE474596 T1 AT E474596T1 AT 05782348 T AT05782348 T AT 05782348T AT 05782348 T AT05782348 T AT 05782348T AT E474596 T1 ATE474596 T1 AT E474596T1
- Authority
- AT
- Austria
- Prior art keywords
- oral administration
- against human
- human papillomavirus
- vaccine against
- papilloma virus
- Prior art date
Links
- 241000701806 Human papillomavirus Species 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 230000000890 antigenic effect Effects 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 241000235347 Schizosaccharomyces pombe Species 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 229940126576 edible vaccine Drugs 0.000 abstract 1
- 229940124866 human papillomavirus vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Botany (AREA)
- Organic Chemistry (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004263580 | 2004-09-10 | ||
| PCT/JP2005/016638 WO2006028214A1 (ja) | 2004-09-10 | 2005-09-09 | 経口投与ワクチン |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE474596T1 true ATE474596T1 (de) | 2010-08-15 |
Family
ID=36036496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05782348T ATE474596T1 (de) | 2004-09-10 | 2005-09-09 | Impfstoff gegen humanes papillomavirus zur oralen verabreichung |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20070154491A1 (de) |
| EP (1) | EP1790332B1 (de) |
| JP (1) | JP4840774B2 (de) |
| KR (1) | KR101187625B1 (de) |
| CN (1) | CN101010099B (de) |
| AT (1) | ATE474596T1 (de) |
| AU (1) | AU2005280896B2 (de) |
| CA (1) | CA2579882C (de) |
| DE (1) | DE602005022458D1 (de) |
| RU (1) | RU2405568C2 (de) |
| WO (1) | WO2006028214A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1869215B (zh) * | 2006-05-19 | 2012-07-04 | 长春百克生物科技股份公司 | 一种制备人乳头瘤病毒的病毒样颗粒的方法 |
| DE102008057451A1 (de) | 2008-11-14 | 2010-05-20 | Martin-Luther-Universität Halle-Wittenberg | Verfahren zur oralen Vakzinierung mittels rekombinanter Hefen |
| DE102009044224A1 (de) * | 2009-10-09 | 2011-04-28 | PomBio Tech GmbH Starterzentrum der Universität des Saarlandes Campus Geb. A1-1 | Methode zur Produktion von HCV Virus-ähnlichen Partikeln |
| US9707457B2 (en) * | 2010-12-28 | 2017-07-18 | Taylor Made Golf Company, Inc. | Golf club |
| US8888607B2 (en) * | 2010-12-28 | 2014-11-18 | Taylor Made Golf Company, Inc. | Fairway wood center of gravity projection |
| CN113710268B (zh) | 2019-03-29 | 2025-07-22 | 国立研究开发法人科学技术振兴机构 | 药物递送组合物 |
| CN111529701A (zh) * | 2020-05-14 | 2020-08-14 | 内蒙古自治区国际蒙医医院(内蒙古自治区蒙医药研究所) | 一种口服后产生新型冠状病毒抗体的制剂及其制备方法 |
| CN119685379A (zh) * | 2024-12-19 | 2025-03-25 | 中国医学科学院生物医学工程研究所 | 一种基因工程化海带基的口服粘膜免疫激活型hpv疫苗及其制备方法和应用 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE122007000085I1 (de) | 1991-07-19 | 2008-03-27 | Univ Queensland St Lucia | Polynukleotidabschnitt des HPV16-Genoms |
| US6153201A (en) | 1993-03-09 | 2000-11-28 | University Of Rochester | Oral immunization with papillomavirus virus-like particles |
| DE69435209D1 (de) * | 1993-03-31 | 2009-06-10 | Zeon Corp | Polypeptid, dafür kodierende DNA, diese DNA beinhaltender, rekombinanter Vektor, Herstellung eines rekombinanten Virus unter Verwendung dieses Vektors und dessen Anwendung |
| IT1270123B (it) | 1994-10-05 | 1997-04-28 | Dompe Spa | Composizioni farmaceutiche contenenti microorganismi ingegnerizzati e loro uso per terapia |
| ES2235176T3 (es) * | 1994-10-24 | 2005-07-01 | THE TEXAS A & M UNIVERSITY SYSTEM | Inmunizacion oral con plantas transgenicas. |
| AU755679B2 (en) | 1997-07-03 | 2002-12-19 | Medimmune, Llc | Homogeneous human papilloma virus capsomere containing compositions, methods for manufacture,and the use thereof as diagnostic, prophylactic or therapy |
| US6228368B1 (en) * | 1997-10-06 | 2001-05-08 | Loyola University Of Chicago | Papilloma virus capsomere formulations and method of use |
| BR9913026A (pt) | 1998-08-14 | 2001-09-25 | Merck & Co Inc | Processo de purificação de partìculas semelhantes a vìrus (vlps) de papilomavìrus recombinante, e, processo de preparação de um produto de vlp de papilomavìrus humano purificado adequado para uso em uma vacina para humano |
| WO2000011140A1 (en) * | 1998-08-20 | 2000-03-02 | The Wistar Institute Of Anatomy And Biology | Methods of augmenting mucosal immunity through systemic priming and mucosal boosting |
| EP1108035B1 (de) | 1998-09-04 | 2007-08-08 | Sanofi Pasteur Limited | Behandlung von gebärmutterhalskrebs |
| US6908613B2 (en) * | 2000-06-21 | 2005-06-21 | Medimmune, Inc. | Chimeric human papillomavirus (HPV) L1 molecules and uses therefor |
| US20050075298A1 (en) * | 2002-01-31 | 2005-04-07 | Wei Chen | Methods and composition for delivering nucleic acids and/or proteins to the intestinal mucosa |
| KR101241272B1 (ko) * | 2002-12-16 | 2013-03-15 | 더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 | 면역 요법으로서의 효모계 백신 |
-
2005
- 2005-09-09 CN CN2005800297816A patent/CN101010099B/zh not_active Expired - Fee Related
- 2005-09-09 DE DE602005022458T patent/DE602005022458D1/de not_active Expired - Lifetime
- 2005-09-09 WO PCT/JP2005/016638 patent/WO2006028214A1/ja not_active Ceased
- 2005-09-09 CA CA2579882A patent/CA2579882C/en not_active Expired - Fee Related
- 2005-09-09 EP EP05782348A patent/EP1790332B1/de not_active Expired - Lifetime
- 2005-09-09 JP JP2006535846A patent/JP4840774B2/ja not_active Expired - Fee Related
- 2005-09-09 AU AU2005280896A patent/AU2005280896B2/en not_active Ceased
- 2005-09-09 RU RU2007113184/15A patent/RU2405568C2/ru not_active IP Right Cessation
- 2005-09-09 KR KR1020077005471A patent/KR101187625B1/ko not_active Expired - Fee Related
- 2005-09-09 AT AT05782348T patent/ATE474596T1/de not_active IP Right Cessation
-
2007
- 2007-03-09 US US11/684,062 patent/US20070154491A1/en not_active Abandoned
-
2008
- 2008-05-07 US US12/116,501 patent/US8282936B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006028214A1 (ja) | 2006-03-16 |
| CA2579882C (en) | 2012-07-17 |
| EP1790332A4 (de) | 2009-02-18 |
| US8282936B2 (en) | 2012-10-09 |
| CN101010099B (zh) | 2011-11-09 |
| AU2005280896A1 (en) | 2006-03-16 |
| CA2579882A1 (en) | 2006-03-16 |
| US20070154491A1 (en) | 2007-07-05 |
| RU2007113184A (ru) | 2008-10-27 |
| EP1790332B1 (de) | 2010-07-21 |
| JPWO2006028214A1 (ja) | 2008-05-08 |
| DE602005022458D1 (de) | 2010-09-02 |
| AU2005280896B2 (en) | 2010-08-05 |
| RU2405568C2 (ru) | 2010-12-10 |
| CN101010099A (zh) | 2007-08-01 |
| JP4840774B2 (ja) | 2011-12-21 |
| EP1790332A1 (de) | 2007-05-30 |
| US20090017063A1 (en) | 2009-01-15 |
| KR101187625B1 (ko) | 2012-10-05 |
| KR20070050465A (ko) | 2007-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2018010I1 (no) | HPV 31 L1 protein | |
| MY139500A (en) | Optimized expression of hpv 58 l1 in yeast | |
| TR201908199T4 (tr) | HPV'ye karşı aşılar. | |
| AP1872A (en) | Virus-like particles of human papillomavirus. | |
| WO2005089164A3 (en) | Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions | |
| MY140664A (en) | Optimized expression of hpv 45 l1 in yeast | |
| EP1917033A4 (de) | Virusähnliche partikel als paramyxovirus-impfstoffe | |
| EP1270016A4 (de) | Aidsvirus-impfstoff unter verwendung eines sendaivirus-vektors | |
| EA200701633A1 (ru) | Вакцина на основе вирусоподобных частиц вируса папилломы человека 16 и вируса папилломы человека 18 l1 | |
| BRPI0816134A2 (pt) | Herpesvírus, sequência de dna, vetor, célula, vírus, método para produção de partículas infecciosas, partículas infecciosas, vacina, uso de herpesvírus ou da sequência de dna ou do vetor ou das partículas infecciosas, e, método para o tratamento preventivo e/ou terapêutico de uma doença. | |
| ATE474596T1 (de) | Impfstoff gegen humanes papillomavirus zur oralen verabreichung | |
| EA201170264A1 (ru) | Вакцина против hpv | |
| JOP20220187A1 (ar) | لقاح فيروس الورم الحليمي البشري (hpv) | |
| MY162658A (en) | Genes encoding major capsid protein l1 of human papilloma virus and use of the same | |
| ATE471990T1 (de) | Transkutane immunisierung gegen papillomavirus mit virusähnlichen papillomaviruspartikeln | |
| EP1427443A4 (de) | Vakzine mit papilloma-virus-e-proteinen, die durch einen viralen vektor abgegeben werden | |
| SE0002498D0 (sv) | Papillomavirus vaccine | |
| ATE526035T1 (de) | Tollwut-impfstoff | |
| EA200702077A1 (ru) | Вакцина | |
| TW200607858A (en) | Optimized expression of HPV 31 L1 in yeast | |
| Dougan | A single-dose, live oral typhoid vaccine: an achievable goal? | |
| WO2021232130A8 (pt) | Construção de ácido nucleico, virus influenza recombinante, método para preparar um virus influenza recombinante, composição, e, uso | |
| WO2006109195A3 (en) | Modulation of an immune response by filamentous haemagglutinin | |
| RU2008131197A (ru) | Способ повышения иммуногенности живых вакцин из rs (sr) | |
| EA201700162A1 (ru) | Оптимизированный гибридный белок вируса папилломы человека для использования в качестве антигена в терапевтической вакцине |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |